Government agencies (note) | - Drug quality and safety
- Drug accessibility
- Corporate governance and ethical operations
- Information security and privacy protection
- Supply chain management
| - On-site visits, phone calls, official correspondence, information disclosure, email, and earnings calls
| - Appoint a specialist to manage correspondence with government agencies, handling a total of 1,716 electronic official documents between January and December 2024, including 772 incoming and 944 outgoing documents.
- All directors meet the standards of "Directions for the Implementation of Continuing Education for Directors and Supervisors of TWSE Listed and TPEx Listed Companies". The total number of training sessions for the 12 directors (including former directors) is 18, with a total of 87 hours.
- In alignment with the Financial Supervisory Commission’s (FSC) Sustainability Roadmap for TWSE/TPEx-listed companies, the 2024 greenhouse gas (GHG) inventory and third-party assurance were completed across major operational sites. In parallel, the TCFD framework has been implemented to address climate change. The GHG inventory and assurance details are shown in the table below:
- -
- GHG Inventory
- Taiwan：Lotus Pharmaceutical Co., Ltd.
- Korea：Alvogen Korea Holdings Ltd., Alvogen Korea Co., Ltd.
- Singapore：Lotus International Pte. Ltd.
- India：Alvogen Pharma India Private Limited, Meishi Pharma Services Private Limited, Norwich Clinical Services Private Limited
- GHG Third-Party Assurance
- Taiwan：Lotus Pharmaceutical Co., Ltd.
- Korea：Alvogen Korea Holdings Ltd., Alvogen Korea Co., Ltd.
- Singapore：Lotus International Pte. Ltd.
- India：Alvogen Pharma India Private Limited, Meishi Pharma Services Private Limited
- The Lotus Taiwan and Korea factories completed a total of 8 inspections. The Taiwan Nantou factory received approval in all 3 inspections. The Korea Hyangnam factory received approval in all 3 MFDS inspections. The Korea Gongju factory underwent 2 MFDS inspections, with one receiving approval, while the other did not meet the required standards due to inconsistencies in some data from the Alvogen Korea outsourced laboratory. After verification, it was confirmed that the product quality was unaffected. The company subsequently reviewed and strengthened the management processes for outsourced laboratories, actively making improvements to ensure future compliance with relevant regulations.
| |
| - Corporate governance and ethical operations
- Drug quality and safety
- Drug accessibility
- Talent attraction and retention
- Business performance
- Information security and privacy protection
- Supply chain management
| - Annual general meetings/annual reports
- Quarterly financial reports
- Announcement of operations overview
- Material Information Announcements, Press Releases, Investor Conferences, Official Company Website, Phone, and Email
| - Held 1 annual general meeting.
- Held 4 earnings release.
- Invited to attend 10 investor meetings/forums.
- There were 67 public announcements made on the Market Observation Post System from January to December 2024.
| |
| - Drug quality and safety
- Talent attraction and retention
- Occupational Safety and Health
- Information security and privacy protection
- Climate action
| - Labor-management meetings and remuneration committee meetings
- Employee engagement surveys and performance evaluations
- Emergency response drills, HR announcements, internal employee portal, two-way communication conferences, town hall meetings, department meetings, internal and external training programs, online learning
- Labor unions (Korea)
| - 4 labor-management meetings were held in Taiwan.
- In the 2024 employee engagement survey, a total of 1,482 questionnaires were sent to employees worldwide, and 1,268 were collected, with a response rate of 87%. The 2024 survey results showed improvements in both engagement and employee experience.
- 7 townhalls two-way communication meetings were held.
- Korean labor union: Total of 28 meetings held from January to December 2024
| |
Medical institutions and customer | - Corporate governance and ethical operations
- Drug quality and safety
- Waste and hazardous chemical management
- Drug accessibility
- Information security and privacy protection
| - Exhibitions, product presentations, academic events and lectures, clinical trials, factory visits, audits, visits, emails, written correspondence, pharmacovigilance and adverse event reporting, drug quality educational sessions
| - Lotus Taiwan organized a total of 333 academic events related to medical products, with 12,985 participants. These events included 134 focused on oncology drugs and 199 on non-oncology drugs.
- 2 major factory visits were organized in Taiwan to provide medical professionals involved in drug quality a deeper understanding of the high-quality products offered by Lotus.
| |
| - Waste and hazardous chemical management
- Drug accessibility
- Business performance
- Information security and privacy protection
- Drug quality and safety
- Corporate governance and ethical operations
| - Supply chain management and audits
| - The Procurement Department planned to audit 25 suppliers in 2024 (13 from Taiwan, 10 from Korea, and 2 joint suppliers), achieving 100% completion of the audits with no significant deficiencies or risks identified.
- The Quality Department planned to audit 135 suppliers in 2024, performing on-site audits for 30 and document-based audits for 104 suppliers, achieving a 99% completion rate. with no significant deficiencies or risks.
- Held our first global Supplier Conference to promote communication among partners. The conference was held in two sessions with over 150 suppliers in attendance.
| |
Patients and non-profit organizations | - Corporate Governance and Ethical Operations
- Drug quality and safety
- Waste and hazardous chemical management
- Drug accessibility
- Cyber security and privacy protection
| - Academic activities / educational Lectures / phone / E-Mail
| - Lotus Taiwan held a total of 142 patient activities, including 3 brain tumor medical seminar, 136 osteoporosis patient events, 2 Parkinson's disease health care series seminars, and 1 men's health education seminar, reaching 11,312 individuals.
- Lotus Taiwan held two volunteer medical services and pharmacist lectures in rural areas of Nantou, providing medical services to a total of 357 residents, with 300 residents attending the pharmacist lectures.
- Lotus Taiwan collaborated with One-Forty, a nonprofit organization dedicated to migrant worker education, to hold a workshop at Nantou Yumin Hospital. Nearly 20 migrant workers attended to enhance their understanding of dementia care.
- Lotus Taiwan donated 7 types of medicines to the 31th Love Knows No Boundaries Free Medical Service for free clinics in Cambodia.
- Lotus Taiwan donated NTD 100,000 to The Garden of Hope Foundation to promote children's and women's rights.
- Combining the Employee Family Day Event with Charity. The company invited employees to collectively donate a total of NTD 400,000 to support the Maria Social Welfare Foundation's "0-3 Year-Old Maria Baby Early Intervention Program."
- Lotus Korea collaborated with Good People International to donate daily hygiene products, amounting to KRW 20 million, to 200 low-income women and teenagers.
- Lotus Korea has continued to hold making bread and kimchi voluntary activities for over 10 years, doating a total of KRW 3.5 million to support these activities.
| |
| - Corporate governance and ethical operations
- Drug quality and safety
- Business performance
- Drug accessibility
- Information security and privacy protection
| - Press release
- Media interview
- Market Observation Post System
- Company website
- Spokesperson
- Media contact mailbox
| - There was a total of 24 press releases related to the Company's website disclosure and operations from January to December 2024.
| |
